Skip to content

Author

Rose Jalang'o

We have 5 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Completion of Hepatitis B Vaccination Schedule Among Healthcare Workers in Four Counties in Kenya: A Mixed-Methods Study

Background/Objectives: Healthcare workers (HCWs) are at an increased risk of hepatitis B virus infection through occupational exposure, yet completion of the recommended hepatitis B vaccination schedule remains suboptimal in Kenya. We assessed vaccination completion, associated factors, motivators, and barriers among H...

Harriet Mirieri, Jeanette Dawa, D. Omia et al. · 0 citations
Open access Aug 2026

Setting the scene for the RTS,S/AS01 malaria vaccine implementation programme in Kenya: a situational analysis of the health system, malaria burden, and immunization platform

Kenya has made notable progress in reducing malaria prevalence and improving child survival, yet the lake-endemic region continues to face high transmission and substantial malaria-related illness and death. To strengthen prevention, the RTS,S/AS01 malaria vaccine was introduced in 2019 through Kenya’s Expanded Progr...

N. Westercamp, Titus K. Kwambai, S. Akech et al. · 0 citations
Open access Sep 2026

Cost-effectiveness and budget impact analyses of strategies to improve measles vaccination coverage in Kenya

It is suggested that accelerating measles coverage through intensified investments towards measles elimination is cost-effective but has a high budget impact and policy makers should consider market shaping interventions and strategies to mobilize and allocate sufficient resources to increase vaccination coverage and e...

Stacey Orangi, P. Mandaliya, Rose Jalang'o et al. · 0 citations
Aug 2026

Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.

BACKGROUND In 2023, novel oral polio vaccine type 2 (nOPV2) was used to respond to an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Kenya. We assessed the immunogenicity of one and two doses of nOPV2 administered during outbreak response. METHODS An observational cohort study was conducted fro...

A. Anand, Damaris Jepkosgei, C. Mwachari et al. · 0 citations
Open access Jan 2026

Impact of Implementing Alternative Human Papillomavirus (HPV) Vaccination Strategies in Kenya: A Modeling Study

Background: Implementation delays reduce population-level effects of evidence-based interventions. We conducted a modeling study to estimate the effect of priority policy decisions on a human papillomavirus (HPV) vaccination program in Kenya. Methods: We used a static cohort model to estimate the health effects and cos...

Valerian Mwenda, Joan-Paula Bor, Rose Jalang’o et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.